TTK Healthcare Ltd
BSE:507747
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TTK Healthcare Ltd
BSE:507747
|
IN |
|
A
|
ARway Corp
CNSX:ARWY
|
CA |
|
S
|
Seobu T&D Co Ltd
KOSDAQ:006730
|
KR |
|
Nanjing Inform Storage Equipment Group Co Ltd
SSE:603066
|
CN |
|
LaserBond Ltd
ASX:LBL
|
AU |
|
GuangZhou Baiyun Electric Equipment Co Ltd
SSE:603861
|
CN |
|
B
|
Bitcoin Crypto Currency Exchange Corp
OTC:ARSC
|
US |
|
O
|
Outokumpu Oyj
OMXH:OUT1V
|
FI |
|
Norsk Hydro ASA
OTC:NHYKF
|
NO |
|
UE Furniture Co Ltd
SSE:603600
|
CN |
|
H
|
Handsome Corp
KRX:020000
|
KR |
|
Z
|
Zhejiang Langdi Group Co Ltd
SSE:603726
|
CN |
|
G
|
Geely Automobile Holdings Ltd
F:GRUA
|
HK |
|
Showa Sangyo Co Ltd
TSE:2004
|
JP |
|
Gentech Holdings Inc
OTC:GTEH
|
US |
|
SS Lazio SpA
MIL:SSL
|
IT |
|
Computacenter PLC
LSE:CCC
|
UK |
|
Integral Diagnostics Ltd
ASX:IDX
|
AU |
|
Digitiliti Inc
OTC:DIGI
|
US |
|
Clever Leaves Holdings Inc
OTC:CLVR
|
CO |
|
Bruker Corp
NASDAQ:BRKR
|
US |
|
P
|
Profithol SA
MAD:SPH
|
ES |
|
Voxtur Analytics Corp
XTSX:VXTR
|
CA |
|
J
|
Jintuo Technology Co Ltd
SSE:603211
|
CN |
Multiples-Based Value
The Multiples-Based Value of one TTKHEALTH stock under the Base Case scenario is hidden INR. Compared to the current market price of 890.65 INR, TTK Healthcare Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
TTKHEALTH Competitors Multiples
TTK Healthcare Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
T
|
TTK Healthcare Ltd
BSE:507747
|
12.5B INR | 1.5 | 20.1 | 11.2 | 16.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.2 | 41.6 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 5.9 | 26.9 | 17.2 | 22 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.2 | 29.8 | 16.4 | 23.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5 | 20.2 | 12.5 | 16.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.1 | 8.2 | 9.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.8B GBP | 2.6 | 15.1 | 8.2 | 10.2 |